logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
R

Robert J. Fountaine

pfizer inc.

11H指数
54论文数
826被引数
收录论文 21
发表时间
logo
Time Course of Rimegepant Effect for Acute Treatment of Migraine in Adults Unsuitable for Triptans: Exploratory Endpoints from a Phase 4, Randomized, Double-Blind, Placebo-Controlled Study利美 gepant 对不适合曲坦类药物的成人急性偏头痛的治疗效果时间过程：一项第 4 期、随机、双盲、安慰剂对照研究的探索性终点
errNeurology and Therapy
IF4.8
err2026-10-03
err0
errOAAI
errMichel Lanteri-Minet; Timothy Smith; Catherine Nalpas; Luz M. Ramirez; Alexandra Thiry; Shannin McCollum; Sara Ramaker; Robert Fountaine
err分享
err收藏
Efficacy and Safety of Oral Zavegepant in Migraine Prevention: A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Study in Patients with Chronic Migraine口服扎维杰潘坦预防偏头痛的疗效与安全性：一项针对慢性偏头痛患者的2/3期随机、双盲、安慰剂对照研究
errPain and Therapy
IF3.3
err2026-08-26
err0
errOAAI
errRobert J. Fountaine; Sergey Dubrovin; Linda Mosher; Jing Liu; Mohamed H. Shahin; Terence Fullerton
err分享
err收藏
Patient-Reported Outcomes During the Acute Treatment of Migraine with Zavegepant Nasal Spray: Results from a 52-Week, Open-Label Study使用Zavegepant鼻喷剂治疗偏头痛急性期的患者报告结局：一项为期52周、开放标签研究的结果
errPain and Therapy
IF3.3
err2025-12-11
err0
errOAAI
errRichard B. Lipton; Linda Mosher; Robert J. Fountaine
err分享
err收藏
A phase 4, 24-week, open-label study to evaluate the safety and tolerability of once-daily dosing of 75 mg rimegepant for episodic migraine prevention一项为期24周的4期、开放标签研究，旨在评估每日一次75 mg瑞美吉潘（rimegepant）用于发作性偏头痛预防的安全性和耐受性。
errThe Journal of Headache and Pain
IF7.9
err2025-12-09
err0
errOAAI
errJeremias Antinew; Robert J. Fountaine; Vittorio Loprinzo; Esther Straghan; Sergey Dubrovin; Patrizia DeBesi; Nick Vatakis; Terence Fullerton
err分享
err收藏
Rimegepant for acute treatment of migraine in triptan-unsuitable adults: A randomized, double-blind, placebo-controlled phase 4 trial瑞美吉潘特用于不适合使用曲坦类药物的成人偏头痛急性治疗：一项随机、双盲、安慰剂对照的4期临床试验
errCephalalgia
IF4.6
err2025-11-18
err0
PREAI
errMessoud Ashina; Peter McAllister; Charly Gaul; Adolfo Leyva-Rendon; Luz M. Ramirez; Catherine Nalpas; Alexandra Thiry; Lucy Abraham; Robert J. Fountaine; Terence Fullerton
err分享
err收藏
A phase 4, randomized, double-blind, placebo-controlled trial evaluating the efficacy and tolerability of rimegepant for the prevention of episodic migraine in adults with a history of inadequate response to traditional oral preventive medications一项4期、随机、双盲、安慰剂对照试验，评估瑞美 gepant 在预防有传统口服预防药物不耐受史成人发作性偏头痛方面的有效性和耐受性。
errCephalalgia
IF4.6
err2025-11-18
err0
errOAAI
errPatricia Pozo-Rosich; José Antonio Gien López; Pawel Lisewski; Ayşe Neslihan Aslan; Harpreet Seehra; Alexandra Thiry; Lucy Abraham; Luz M. Ramirez; Robert Fountaine; Terence Fullerton
err分享
err收藏
Rimegepant for the acute treatment of migraine: A phase 3, multicenter, open-label, long-term safety and effectiveness study in adults from China瑞美吉潘特用于成人偏头痛急性治疗：一项在中国成人中进行的第3期、多中心、开放标签、长期安全性和有效性研究
errCephalalgia
IF4.6
err2025-10-09
err0
errOAAI
errMingjie Zhang; Aihong Guo; Jin Wu; Hebo Wang; Yongbo Zhang; Hongjuan Dong; Jianguang Liu; Bei Zhang; Huailian Guo; Tingmin Yu; Zhihong Lu; Liheng Ma; Robert J. Fountaine; Glenn C. Pixton; Qi Zhong; Xiaoran Han; Shengyuan Yu
err分享
err收藏
Efficacy and safety of rimegepant 75 mg for acute treatment of migraine: a pooled analysis of four randomized, placebo-controlled trials瑞美吉泮75 mg治疗急性偏头痛的疗效与安全性：一项四项随机、安慰剂对照试验的合并分析
errPostgraduate Medicine
IF2.8
err2025-06-13
err0
PREAI
errStewart J. Tepper; Jelena M. Pavlovic; Shengyuan Yu; Richard B. Lipton; Glenn Pixton; Yunjun Zou; Robert J. Fountaine; David Semel
err分享
err收藏
Long-term safety and tolerability of zavegepant 10-mg nasal spray with concomitant use of anti-calcitonin gene-related peptide monoclonal antibodies or other select preventive migraine medications: Results from a phase 2/3 open-label studyZavegepant 10-mg鼻喷雾剂长期使用的安全性与耐受性：联合使用抗降钙素基因相关肽单克隆抗体或其他选择性偏头痛预防药物的结果——一项开放标签的II/III期研究结果
errHEADACHE
IF4
err2025-05-20
err0
PREAI
errGary Berman MD, CPI, FAHS; Kathleen Mullin MD; Timothy Smith MD, RPh; Linda Mosher MA; Samantha Sweeney PharmD, MBA; Robert J. Fountaine PharmD
err分享
err收藏
Oral Nirmatrelvir-Ritonavir as Postexposure Prophylaxis for Covid-19
errNEW ENGLAND JOURNAL OF MEDICINE
IF78.5
err2024-07-18
err1
PREAI
errHammond, Jennifer; Yunis, Carla; Fountaine, Robert J.; Luscan, Gerald; Burr, Aimee M.; Zhang, Wuyan; Wisemandle, Wayne; Soares, Holly; Baniecki, Mary Lynn; Hendrick, Victoria M.; Kalfov, Veselin; Pypstra, Rienk; Rusnak, James M.
err分享
err收藏
Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19
errNEW ENGLAND JOURNAL OF MEDICINE
IF78.5
err2024-04-04
err25
errOAAI
errHammond, Jennifer; Fountaine, Robert J.; Yunis, Carla; Fleishaker, Dona; Almas, Mary; Bao, Weihang; Wisemandle, Wayne; Baniecki, Mary Lynn; Hendrick, Victoria M.; Kalfov, Veselin; Simon-Campos, J. Abraham; Pypstra, Rienk; Rusnak, James M.
err分享
err收藏
Characterization of adverse joint outcomes in patients with osteoarthritis treated with subcutaneous tanezumab
errOSTEOARTHRITIS AND CARTILAGE
IF9
err2023-12-01
err5
errOAAI
errCarrino, John A.; McAlindon, Timothy E.; Schnitzer, Tom J.; Guermazi, Ali; Hochberg, Marc C.; Conaghan, Philip G.; Brown, Mark T.; Burr, Aimee; Fountaine, Robert J.; Pixton, Glenn C.; Viktrup, Lars; Verburg, Kenneth M.; West, Christine R.
err分享
err收藏
Neurological safety of subcutaneous tanezumab versus NSAID in patients with osteoarthritis
errJOURNAL OF THE NEUROLOGICAL SCIENCES
IF3.2
err2022-03-01
err4
errOAAI
errBrown, Mark T.; Sandroni, Paola; Low, Phillip A.; Gorson, Kenneth C.; Hunter, David J.; Pixton, Glenn C.; Fountaine, Robert J.; Viktrup, Lars; West, Christine R.; Verburg, Kenneth M.
err分享
err收藏
Long-Term Safety and Efficacy of Subcutaneous Tanezumab Versus Nonsteroidal Antiinflammatory Drugs for Hip or Knee Osteoarthritis: A Randomized Trial
errARTHRITIS & RHEUMATOLOGY
IF10.9
err2021-06-07
err40
PREAI
errHochberg, Marc C.; Carrino, John A.; Schnitzer, Thomas J.; Guermazi, Ali; Walsh, David A.; White, Alexander; Nakajo, Satoru; Fountaine, Robert J.; Hickman, Anne; Pixton, Glenn; Viktrup, Lars; Brown, Mark T.; West, Christine R.; Verburg, Kenneth M.
err分享
err收藏
Novel Application of the Two-Period Microtracer Approach to Determine Absolute Oral Bioavailability and Fraction Absorbed of Ertugliflozin
errCTS-CLINICAL AND TRANSLATIONAL SCIENCE
IF2.8
err2018-03-25
err33
errOAAI
errRaje, Sangeeta; Callegari, Ernesto; Sahasrabudhe, Vaishali; Vaz, Alfin; Shi, Haihong; Fluhler, Eric; Woolf, Eric J.; Schildknegt, Klaas; Matschke, Kyle; Alvey, Christine; Zhou, Susan; Papadopoulos, Dimitris; Fountaine, Robert; Saur, Didier; Terra, Steven G.; Stevens, Lloyd; Gaunt, Daniel; Cutler, David L.
err分享
err收藏
Efficacy and Safety of CP-945,598, a Selective Cannabinoid CB1 Receptor Antagonist, on Weight Loss and Maintenance
errOBESITY
IF4.7
err2012-09-10
err26
errOAAI
errAronne, Louis J.; Finer, Nick; Hollander, Priscilla A.; England, Richard D.; Klioze, Solomon S.; Chew, Robert D.; Fountaine, Robert J.; Powell, Coralie M.; Obourn, John D.
err分享
err收藏
Increased Food Intake and Energy Expenditure Following Administration of Olanzapine to Healthy Men
errOBESITY
IF4.7
err2012-09-06
err82
errOAAI
errFountaine, Robert J.; Taylor, Ann E.; Mancuso, James P.; Greenway, Frank L.; Byerley, Lauri O.; Smith, Steven R.; Most, Marlene M.; Fryburg, David A.
err分享
err收藏
Acute passive cigarette smoke exposure and inhaled human insulin (Exubera®) pharmacokinetics急性被动香烟烟雾暴露和吸入人胰岛素 (Exubera®) 药代动力学
errBRITISH JOURNAL OF CLINICAL PHARMACOLOGY
IF3
err2008-06-28
err9
errOAAI
errFountaine, Robert; Milton, Ashley; Checchio, Tina; Wei, Greg; Stolar, Marilyn; Teeter, John; Jaeger, Rudolph; Fryburg, David
err分享
err收藏
The effect of smoking cessation and subsequent resumption on absorption of inhaled insulin
errDIABETES CARE
IF16.6
err2006-02-01
err57
errOAAI
errBecker, RHA; Frick, AD; Sha, S; Fountaine, RJ
err分享
err收藏
Pharmacokinetics (PK) and pharmacodynamics (PD) of daily lasofoxifene (LASO) in Japanese (J) and Caucasian (C) postmenopausal (PM) women
errCLINICAL PHARMACOLOGY & THERAPEUTICS
IF5.5
err2005-02-01
err0
errOAAI
errFountaine, R; Nishizawa, Y; Gardner, MJ
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
D
David J. Hunter
H 指数: 204 · 论文数: 2.5K
R
Richard B. Lipton
H 指数: 178 · 论文数: 1.8K
刘建军 封面图
刘建军 (Jianjun Liu)
H 指数: 131 · 论文数: 2.6K
M
Marc C. Hochberg
H 指数: 129 · 论文数: 832
P
Philip G. Conaghan
H 指数: 116 · 论文数: 1.2K
查看更多